Effects of Activin and TGFβ on p21 in Colon cancer

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Bauer, Jessica ^a   Sporn, Judith C ^a   Cabral, Jennifer ^b   Gomez, Jessica ^b   Jung, Barbara ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN; ACTIVIN RECEPTOR 2; MESSENGER RNA; PROTEIN P21; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER TISSUE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; COLON CANCER; CONTROLLED STUDY; DOWN REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; UBIQUITINATION; UPREGULATION; WESTERN BLOTTING;

ACTIVINS; APOPTOSIS; COLON; COLONIC NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; HUMANS; PHOSPHORYLATION; PROTEASOME ENDOPEPTIDASE COMPLEX; SIGNAL TRANSDUCTION; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED; UBIQUITINATION;

EID: 84862742711     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039381     Document Type: Article

References (36)

1. Chen YG, Lui HM, Lin SL, Lee JM, Ying SY, (2002) Regulation of cell proliferation, apoptosis, and carcinogenesis by activin. Exp Biol Med (Maywood) 227: 75-87.
2. Lee YJ, Hong KH, Yun J, Oh SP, (2006) Generation of activin receptor type IIB isoform-specific hypomorphic alleles. Genesis 44: 487-494.
3. Mori Y, Yin J, Rashid A, Leggett BA, Young J, et al. (2001) Instabilotyping: comprehensive identification of frameshift mutations caused by coding region microsatellite instability. Cancer Res 61: 6046-6049.
4. Hempen PM, Zhang L, Bansal RK, Iacobuzio-Donahue CA, Murphy KM, et al. (2003) Evidence of selection for clones having genetic inactivation of the activin A type II receptor (ACVR2) gene in gastrointestinal cancers. Cancer Res 63: 994-999.
5. Deacu E, Mori Y, Sato F, Yin J, Olaru A, et al. (2004) Activin type II receptor restoration in ACVR2-deficient colon cancer cells induces transforming growth factor-beta response pathway genes. Cancer Res 64: 7690-7696.
6. Jung B, Doctolero RT, Tajima A, Nguyen AK, Keku T, et al. (2004) Loss of activin receptor type 2 protein expression in microsatellite unstable colon cancers. Gastroenterology 126: 654-659.
7. Jung B, Smith EJ, Doctolero RT, Gervaz P, Alonso JC, et al. (2006) Influence of target gene mutations on survival, stage and histology in sporadic microsatellite unstable colon cancers. Int J Cancer 118: 2509-2513.
8. Grady WM, Carethers JM, (2008) Genomic instability and molecular pathogenesis of colorectal cancer. Gastroenterology 4: 1079-1099.
9. Watanabe T, Wu TT, Catalano PJ, Ueki T, Satriano R, et al. (2001) Molecular predictors of survival after adjuvant chemotherapy for colon cancer. N Engl J Med 344: 1196-1206.
10. Abbas T, Dutta A, (2009) p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer 9: 400-414.
11. Gong J, Ammanamanchi S, Ko TC, Brattain MG, (2003) Transforming growth factor beta 1 increases the stability of p21/WAF1/CIP1 protein and inhibits CDK2 kinase activity in human colon carcinoma FET cells. Cancer Res 63: 3340-3346.
12. Yamato K, Koseki T, Ohguchi M, Kizaki M, Ikeda Y, et al. (1997) Activin A induction of cell-cycle arrest involves modulation of cyclin D2 and p21CIP1/WAF1 in plasmacytic cells. Mol Endocrinol 11: 1044-1052.
13. Burdette JE, Jeruss JS, Kurley SJ, Lee EJ, Woodruff TK, (2005) Activin A mediates growth inhibition and cell cycle arrest through Smads in human breast cancer cells. Cancer Res 65: 7968-7975.
14. Satia JA, Keku T, Galanko JA, Martin C, Doctolero RT, et al. (2005) Diet, lifestyle, and genomic instability in the North Carolina Colon Cancer Study. Cancer Epidemiol Biomarkers Prev 14: 429-436.
15. Satia-Abouta J, Galanko JA, Martin CF, Potter JD, Ammerman A, et al. (2003) Associations of micronutrients with Colon Cancer risk in African Americans and whites: results from the North Carolina Colon Cancer Study. Cancer Epidemiol Biomarkers Prev 12: 747-754.
16. Boyd D, Florent G, Kim P, Brattain M, (1988) Determination of the levels of urokinase and its receptor in human colon carcinoma cell lines. Cancer research 48: 3112-3116.
17. Piek E, Van Dinther M, Parks WT, Sallee JM, Bottinger EP, et al. (2004) RLP, a novel Ras-like protein, is an immediate-early transforming growth factor-beta (TGF-beta) target gene that negatively regulates transcriptional activity induced by TGF-beta. Biochem J 383: 187-199.
18. Chen Y, Lebrun JJ, Vale W, (1996) Regulation of transforming growth factor beta- and activin-induced transcription by mammalian Mad proteins. Proc Natl Acad Sci U S A 93: 12992-12997.
19. Chow JY, Cabral JA, Chang J, Carethers JM, (2008) TGFbeta modulates PTEN expression independently of SMAD signaling for growth proliferation in colon cancer cells. Cancer Biol Ther 7: 1694-1699.
20. Jung BH, Beck SE, Cabral J, Chau E, Cabrera BL, et al. (2007) Activin type 2 receptor restoration in MSI-H colon cancer suppresses growth and enhances migration with activin. Gastroenterology 132: 633-644.
21. Beck SE, Jung BH, Del Rosario E, Gomez J, Carethers JM, (2007) BMP-induced growth suppression in colon cancer cells is mediated by p21WAF1 stabilization and modulated by RAS/ERK. Cell Signal 19: 1465-1472.
22. Zhang B, Halder SK, Kashikar ND, Cho YJ, Datta A, et al. (2010) Antimetastatic role of Smad4 signaling in colorectal cancer. Gastroenterology 138: 969-980 e961-963.
23. Grau AM, Datta PK, Zi J, Halder SK, Beauchamp RD, (2006) Role of Smad proteins in the regulation of NF-kappaB by TGF-beta in colon cancer cells. Cell Signal 18: 1041-1050.
24. Bendjennat M, Boulaire J, Jascur T, Brickner H, Barbier V, et al. (2003) UV irradiation triggers ubiquitin-dependent degradation of p21(WAF1) to promote DNA repair. Cell 114: 599-610.
25. Sheaff RJ, Singer JD, Swanger J, Smitherman M, Roberts JM, et al. (2000) Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination. Mol Cell 5: 403-410.
26. Grady WM, Rajput A, Myeroff L, Liu DF, Kwon K, et al. (1998) Mutation of the type II transforming growth factor-beta receptor is coincident with the transformation of human colon adenomas to malignant carcinomas. Cancer Res 58: 3101-3104.
27. Munoz NM, Upton M, Rojas A, Washington MK, Lin L, et al. (2006) Transforming growth factor beta receptor type II inactivation induces the malignant transformation of intestinal neoplasms initiated by Apc mutation. Cancer Res 66: 9837-9844.
28. Hwang CY, Lee C, Kwon KS, (2009) Extracellular signal-regulated kinase 2-dependent phosphorylation induces cytoplasmic localization and degradation of p21Cip1. Mol Cell Biol 29: 3379-3389.
29. Datto M, Wang XF, (2005) Ubiquitin-mediated degradation a mechanism for fine-tuning TGF-beta signaling. Cell 121: 2-4.
30. Bukholm IK, Nesland JM, (2000) Protein expression of p53, p21 (WAF1/CIP1), bcl-2, Bax, cyclin D1 and pRb in human colon carcinomas. Virchows Arch 436: 224-228.
31. Polyak K, Hamilton SR, Vogelstein B, Kinzler KW, (1996) Early alteration of cell-cycle-regulated gene expression in colorectal neoplasia. Am J Pathol 149: 381-387.
32. Zirbes TK, Baldus SE, Moenig SP, Nolden S, Kunze D, et al. (2000) Prognostic impact of p21/waf1/cip1 in colorectal cancer. Int J Cancer 89: 14-18.
33. Mitomi H, Mori A, Kanazawa H, Nishiyama Y, Ihara A, et al. (2005) Venous invasion and down-regulation of p21(WAF1/CIP1) are associated with metastasis in colorectal carcinomas. Hepatogastroenterology 52: 1421-1426.
34. Shah MA, Kortmansky J, Motwani M, Drobnjak M, Gonen M, et al. (2005) A phase I clinical trial of the sequential combination of irinotecan followed by flavopiridol. Clin Cancer Res 11: 3836-3845.
35. Rau B, Sturm I, Lage H, Berger S, Schneider U, et al. (2003) Dynamic expression profile of p21WAF1/CIP1 and Ki-67 predicts survival in rectal carcinoma treated with preoperative radiochemotherapy. J Clin Oncol 21: 3391-3401.
36. Grady WM, Rajput A, Myeroff L, Liu DF, Kwon K, et al. (1998) Mutation of the type II transforming growth factor-beta receptor is coincident with the transformation of human colon adenomas to malignant carcinomas. Cancer research 58: 3101-3104.